03/07/2025
We are in the final stretch of recruiting for the SiroSkin trial, which is testing a promising topical treatment to reduce facial skin cancers in organ transplant recipients.
In Australia, there are approximately 12,000 solid organ transplant recipients and around 1,600 new transplants occur each year. These patients experience a high incidence of skin cancers, which results in a major dependence on regular skin checks and surgeries.
The SiroSkin trial will provide high-quality data to determine if the topical treatment can significantly reduce the amount of facial skin cancers experienced by solid organ transplant recipients.
The trial is open at 6 sites across Victoria, New South Wales and Queensland. If you or someone you know is eligible, now is the time to get involved and help advance life-changing research. Be one of the final 5 to make a difference!
Learn more about the SiroSkin trial: https://www.masc.org.au/siroskin/